Gel electrophoretic distinction between Congo Red nonreactive beta‐amyloid (1—42) and beta‐amyloid (1—40)
暂无分享,去创建一个
[1] S. Brining. Predicting the In Vitro Toxicity of Synthetic Beta-Amyloid (1-40) , 1997, Neurobiology of Aging.
[2] A. Chrambach,et al. Gel electrophoretic distinction between toxic and nontoxic forms of beta‐amyloid (1—40) , 1999, Electrophoresis.
[3] T. Iwatsubo,et al. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43) , 1994, Neuron.
[4] J. Ménard,et al. Gel Electkophoretic Separation of Angiotensins I, II and III , 1985 .
[5] Xiongfong Chen,et al. Simultaneous assessment of conformation and aggregation of β‐amyloid peptide using electrospray ionization mass spectrometry , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[6] P. Lansbury,et al. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. , 1993, Biochemistry.
[7] A. Chrambach. The Practice of Quantitative Gel Electrophoresis , 1985 .
[8] P. Mager. Molecular simulation of the primary and secondary structures of the Aβ(1‐42)‐peptide of Alzheimer's disease , 1998, Medicinal research reviews.
[9] D. Mann,et al. Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in down Syndrome , 1995, Annals of neurology.